What Is TB-500? Uses, Benefits, Safety, FDA Status, and Evidence
Medical review note: This article is for educational purposes only and does not provide medical advice. TB-500 is not FDA-approved for human therapeutic use. Products sold online as TB-500, thymosin beta-4 fragment, or “research use only” TB-500 may carry serious safety, quality, and legal risks.
Quick answer
TB-500 is commonly described as a synthetic peptide fragment related to thymosin beta-4, a naturally occurring protein involved in actin regulation, cell migration, angiogenesis, and tissue-repair biology. TB-500 is widely marketed online for injury recovery, wound healing, tendon repair, muscle repair, and inflammation, but the strongest evidence comes mostly from thymosin beta-4 animal and laboratory studies, not large controlled human trials of TB-500 itself. TB-500 is not FDA-approved, FDA has identified safety concerns for compounded thymosin beta-4 fragment products, and WADA prohibits thymosin beta-4 and its derivatives, including TB-500, in competitive sport.
Key facts about TB-500
| Question | Answer |
|---|---|
| What is TB-500? | A synthetic peptide commonly described as a fragment related to thymosin beta-4. |
| Other names | Thymosin beta-4 fragment, thymosin beta-4 fragment LKKTETQ, TB4 fragment. |
| Peptide class | Tissue-repair peptide / thymosin beta-4-related peptide. |
| Main mechanism | Proposed effects on actin regulation, cell migration, angiogenesis, inflammation, and tissue repair pathways. |
| FDA-approved? | No. TB-500 is not an FDA-approved drug. |
| Main studied uses | Wound healing, tissue repair, angiogenesis, corneal repair, dermal healing, and injury-repair models. |
| Human evidence level | Limited for TB-500 specifically; most evidence comes from thymosin beta-4 research, not online TB-500 products. |
| Animal/lab evidence level | Substantial thymosin beta-4 preclinical literature. |
| Common online claims | “Injury recovery,” “tendon repair,” “muscle repair,” “wound healing,” “anti-inflammatory,” “joint recovery,” “athletic recovery.” |
| Sports status | Prohibited by WADA; thymosin beta-4 and derivatives such as TB-500 are listed as prohibited. |
| Main safety concern | Lack of human exposure data for TB-500 drug products, possible immunogenicity, aggregation, peptide impurities, API characterization issues, and unapproved online products. |
What is TB-500?
TB-500 is a synthetic peptide commonly described as a fragment related to thymosin beta-4. Thymosin beta-4 is a naturally occurring peptide/protein involved in actin binding, cell movement, angiogenesis, inflammation, and wound-repair biology.
The important distinction is this:
TB-500 is not always the same thing as full thymosin beta-4. Many studies cited by peptide sellers are studies of thymosin beta-4, not necessarily the exact TB-500 fragment sold online.
A PubMed-indexed study on thymosin beta-4 and wound healing reported that thymosin beta-4 accelerated wound healing in a rat full-thickness wound model. Another PubMed-indexed study described thymosin beta-4 as promoting angiogenesis and wound repair in rodent models.
Those findings are scientifically interesting. They do not prove that online TB-500 products are safe, effective, accurately labeled, sterile, or clinically useful in humans.
How does TB-500 work?
TB-500 is discussed in relation to thymosin beta-4 biology. Thymosin beta-4 is involved in actin regulation, which affects cell migration and tissue repair. Research on thymosin beta-4 has also explored angiogenesis, inflammation, corneal wound healing, dermal healing, and tissue regeneration.
Proposed mechanisms include:
- Actin regulation
- Cell migration
- Angiogenesis
- Wound repair signaling
- Inflammatory modulation
- Tissue remodeling
- Possible effects on endothelial cells
- Possible effects on repair after injury
A PubMed review on thymosin beta-4 and angiogenesis describes mechanisms by which thymosin beta-4 regulates angiogenesis and its role in wound healing and tumor progression. A PubMed review on thymosin beta-4 as a regenerative peptide describes thymosin beta-4 as a naturally occurring peptide involved in repair and regeneration of injured cells and tissues.
But mechanism is not proof.
A proposed tissue-repair mechanism does not prove that TB-500 heals tendon injuries, repairs muscles, reduces pain, improves athletic recovery, or safely treats joint problems in humans. The quality of evidence depends on controlled human studies of the actual compound, route, dose, formulation, and patient population.
What is TB-500 used for?
TB-500 is commonly discussed for injury recovery, tendon repair, muscle repair, wound healing, joint recovery, inflammation, and athletic performance. These uses differ sharply in evidence quality.
| Use | Evidence level | What is known | What is not known |
|---|---|---|---|
| Wound healing | Mostly thymosin beta-4 preclinical evidence | Animal studies show thymosin beta-4 can influence wound-healing processes. | Human efficacy for TB-500 products sold online is not established. |
| Tendon repair | Weak / extrapolated | Online claims are common. | Strong controlled human evidence for TB-500 in tendon injury is lacking. |
| Muscle repair | Weak / extrapolated | Thymosin beta-4 biology is related to tissue repair. | TB-500 is not proven as a safe muscle-repair treatment in humans. |
| Joint recovery | Unsupported / weak | Often marketed by peptide clinics and influencers. | Human clinical evidence is not strong. |
| Corneal wound healing | Thymosin beta-4 research | Thymosin beta-4 has been studied for corneal wound healing. | This does not establish online TB-500 for general recovery. |
| Athletic recovery | Unsupported and prohibited | Athletes may seek it for recovery. | WADA prohibits thymosin beta-4 and derivatives such as TB-500. |
| Anti-inflammatory effects | Preliminary / mechanistic | Thymosin beta-4 research includes inflammatory pathways. | Broad human anti-inflammatory use is not established. |
| Online research-use TB-500 | High uncertainty | Sellers market it as a peptide product. | Quality, sterility, identity, concentration, and legality may be unknown. |
What does the research show?
Human evidence
The human evidence for TB-500 specifically is weak.
Some clinical research exists around thymosin beta-4 or thymosin beta-4-related products, but that should not be carelessly transferred to every TB-500 vial sold online.
A ClinicalTrials.gov record for thymosin beta-4 in venous stasis ulcers describes a study of thymosin beta-4 in wound healing. Clinical research records like this are useful, but they do not mean TB-500 is FDA-approved or proven for injury recovery.
The practical interpretation:
TB-500 should not be treated as clinically proven for tendon repair, muscle repair, joint recovery, or athletic recovery in humans.
Animal and laboratory evidence
Most of the supportive evidence comes from thymosin beta-4 preclinical research.
A PubMed-indexed rat wound-healing study found that thymosin beta-4 accelerated wound healing in a rat model. A PubMed-indexed study on wound repair and angiogenesis reported that thymosin beta-4 promoted angiogenesis and wound repair in normal and aged rodents. A PubMed-indexed study on dermal healing reported accelerated dermal healing in multiple animal models.
The practical interpretation:
Thymosin beta-4 has meaningful preclinical repair biology. But preclinical thymosin beta-4 evidence is not the same as human clinical proof for TB-500.
Evidence limitation: thymosin beta-4 vs TB-500
This is the most important scientific nuance.
Many articles and vendors imply that all thymosin beta-4 research proves TB-500 benefits. That is not rigorous. TB-500 is commonly described as a fragment related to thymosin beta-4. A fragment can have overlapping activity, different activity, weaker activity, stronger activity, or different safety behavior depending on sequence, dose, route, purity, stability, and formulation.
The practical interpretation:
Research on thymosin beta-4 should be treated as related background evidence, not direct proof that online TB-500 products work.
Evidence summary
| Claim | Evidence verdict | Explanation |
|---|---|---|
| “TB-500 is related to thymosin beta-4.” | Supported | TB-500 is commonly described as a thymosin beta-4 fragment. |
| “Thymosin beta-4 supports wound-healing biology.” | Supported preclinically | Animal and lab studies show effects on wound healing, angiogenesis, and tissue repair pathways. |
| “TB-500 heals tendon injuries in humans.” | Not established | Strong controlled human evidence for TB-500 tendon repair is lacking. |
| “TB-500 repairs muscle injuries.” | Not established | This is mostly extrapolated from thymosin beta-4 repair biology. |
| “TB-500 reduces inflammation.” | Preliminary / mechanistic | Thymosin beta-4 may influence inflammatory pathways, but broad clinical use is not proven. |
| “TB-500 is FDA-approved.” | False | TB-500 is not FDA-approved. |
| “TB-500 is safe because it is similar to a natural peptide.” | False | Similarity to a natural peptide does not establish safety, especially for injectable products. |
| “TB-500 is allowed for athletes.” | False | WADA lists thymosin beta-4 and derivatives such as TB-500 as prohibited. |
| “Research-use TB-500 is clinically proven.” | False | Research-use products are not FDA-approved consumer therapeutic products. |
Is TB-500 FDA-approved?
No. TB-500 is not FDA-approved.
The FDA page on bulk drug substances that may present significant safety risks discusses thymosin beta-4 fragment LKKTETQ, also known as TB-500. FDA says compounded drugs containing thymosin beta-4 fragment may pose immunogenicity risk for certain routes of administration due to aggregation and peptide-related impurities. FDA also says it has not identified human exposure data for drug products containing thymosin beta-4 fragment.
FDA’s bulk drug substances document states that thymosin beta-4 fragment LKKTETQ, also known as TB-500, had been removed from category 2 because the nomination was withdrawn, while FDA announced plans to consult the Pharmacy Compounding Advisory Committee regarding potential inclusion of TB-500-related bulk drug substances on the 503A bulks list.
The key distinction:
TB-500 is not an FDA-approved prescription drug, and FDA has identified safety concerns in the compounding context.
Is TB-500 legal?
TB-500’s legal status depends on product type, intended use, and jurisdiction, but the practical answer is simple:
TB-500 is not an FDA-approved drug, and online availability does not mean it is legally marketed for human therapeutic use.
Some sellers market TB-500 as a research peptide. That does not make it safe, approved, or appropriate for consumer use.
The blunt version:
Buying “research use only” TB-500 from an online seller is not the same as receiving an FDA-approved prescription drug from a legitimate pharmacy.
Is TB-500 banned in sports?
Yes. TB-500 is prohibited in competitive sport.
USADA’s 2018 Prohibited List summary states that thymosin beta-4 and its derivatives, such as TB-500, were added as examples of prohibited growth factors.
The WADA 2025 Prohibited List lists thymosin beta-4 and its derivatives, including TB-500, among prohibited growth factors and growth factor modulators.
For athletes, the answer is simple:
Do not use TB-500 if you are subject to anti-doping rules.
Safety and side effects
TB-500 has not been adequately established as safe for human therapeutic use.
Possible or theoretical concerns include:
- Immunogenicity risk
- Peptide aggregation
- Peptide-related impurities
- Sterility risk
- Dosing variability
- Mislabeling
- Injection-site reactions
- Unknown systemic effects
- Potential unintended tissue-growth or angiogenesis-related effects
- Product-quality risk from online sellers
- Anti-doping consequences for athletes
FDA specifically flags thymosin beta-4 fragment, also known as TB-500, for possible immunogenicity risk due to aggregation and peptide-related impurities, and says it has not identified human exposure data for drug products containing it.
A serious evaluation of TB-500 should separate controlled thymosin beta-4 research from online peptide products.
TB-500 vs similar peptides
| Compound | Category | Main difference |
|---|---|---|
| TB-500 | Thymosin beta-4 fragment-related peptide | Commonly marketed for recovery and tissue repair, but not FDA-approved and prohibited in sport. |
| Thymosin beta-4 | Naturally occurring peptide/protein | Studied for wound healing, angiogenesis, corneal repair, and tissue-repair biology. |
| BPC-157 | Experimental repair peptide | Different peptide, mostly preclinical tissue-repair and gut-protection evidence. |
| GHK-Cu | Copper peptide | Best known for skin remodeling, collagen, and wound-healing research. |
| CJC-1295 | GHRH analog | Growth-hormone secretagogue category, not a thymosin peptide. |
| Tesamorelin | GHRH analog | FDA-approved for HIV-associated abdominal lipodystrophy, not a tissue-repair peptide. |
The key distinction:
TB-500 belongs in the thymosin beta-4-related repair-peptide category. It is not a GLP-1 drug, growth hormone secretagogue, or FDA-approved recovery medication.
Why is TB-500 sold as “research use only”?
Some online sellers use “research use only” language to sell TB-500 outside normal prescription-drug channels.
That label is not a trust signal.
A serious reader should understand this distinction:
| Product type | What it means |
|---|---|
| Thymosin beta-4 research product | Used in controlled research contexts. |
| FDA-approved TB-500 drug | Does not currently exist. |
| Compounded TB-500 | FDA has identified safety concerns for thymosin beta-4 fragment in compounding context. |
| Research-use TB-500 | Not an FDA-approved consumer therapeutic product. |
| Online peptide TB-500 | Higher risk for identity, sterility, dosing, and quality problems. |
How to evaluate TB-500 claims online
| Claim | What to verify |
|---|---|
| “FDA-approved TB-500” | False. TB-500 is not FDA-approved. |
| “Clinically proven recovery peptide” | Check whether the evidence is from human TB-500 studies or thymosin beta-4 animal studies. |
| “Heals tendons” | Look for controlled human tendon-injury trials, not animal wound-healing models only. |
| “Repairs muscle” | This is usually extrapolated from repair biology, not proven clinical use. |
| “No side effects” | False. FDA has identified safety concerns and lacks human exposure data. |
| “Research use only” | This does not mean safe, legal, approved, or appropriate for human use. |
| “Safe for athletes” | False. WADA prohibits thymosin beta-4 and derivatives such as TB-500. |
| “Same as thymosin beta-4” | Not necessarily. TB-500 is commonly described as a fragment, and fragment activity cannot be assumed identical. |
| “Third-party tested” | Ask for batch-specific HPLC, LC-MS, identity, purity, sterility, and endotoxin data. |
Bottom line
TB-500 is a thymosin beta-4-related synthetic peptide fragment commonly marketed for injury recovery, wound healing, tendon repair, muscle repair, and joint recovery. The scientific basis comes largely from thymosin beta-4 research in animal and laboratory models, not strong controlled human trials proving that TB-500 products sold online are safe or effective.
The most defensible conclusion is:
TB-500 is biologically interesting but clinically unproven for most marketed uses. It is not FDA-approved, FDA has identified safety concerns around thymosin beta-4 fragment products, and athletes should avoid it because WADA prohibits thymosin beta-4 and derivatives such as TB-500.
FAQ
What is TB-500?
TB-500 is commonly described as a synthetic peptide fragment related to thymosin beta-4, a naturally occurring peptide involved in actin regulation, cell migration, angiogenesis, and tissue-repair biology.
What does TB-500 do?
TB-500 is marketed for injury recovery, wound healing, tendon repair, muscle repair, and inflammation. However, most supportive evidence comes from thymosin beta-4 preclinical research, not strong human clinical trials of TB-500 itself.
Is TB-500 FDA-approved?
No. TB-500 is not FDA-approved. FDA has identified safety concerns around thymosin beta-4 fragment products in the compounding context.
Is TB-500 the same as thymosin beta-4?
Not necessarily. TB-500 is commonly described as a fragment related to thymosin beta-4. Research on full thymosin beta-4 does not automatically prove that TB-500 products sold online are safe or effective.
Does TB-500 heal tendons?
Tendon-healing claims are not established by strong human clinical evidence. They are mostly extrapolated from thymosin beta-4 tissue-repair biology and preclinical studies.
Does TB-500 help muscle recovery?
Muscle-recovery claims are not well established. TB-500 is marketed for this purpose, but strong controlled human evidence is lacking.
Is TB-500 safe?
TB-500 does not have enough human safety data to call it safe. FDA says it has not identified human exposure data for drug products containing thymosin beta-4 fragment and warns about possible immunogenicity from aggregation and peptide-related impurities.
Is TB-500 legal?
TB-500 is not an FDA-approved drug. Online sales as a research peptide do not mean it is legally marketed for human therapeutic use.
Is TB-500 banned in sports?
Yes. WADA prohibits thymosin beta-4 and its derivatives, including TB-500. Athletes subject to anti-doping rules should avoid it.
Why do sellers call TB-500 “research use only”?
Sellers often use “research use only” language because TB-500 is not FDA-approved for consumer therapeutic use. The phrase does not make the product safe, legal, approved, or clinically proven.
What is the biggest risk with TB-500?
The biggest risks are using an unapproved injectable peptide without strong human evidence, relying on thymosin beta-4 animal studies as if they prove TB-500 efficacy, and buying online products with uncertain identity, purity, sterility, concentration, and safety.
Sources
- FDA: Certain Bulk Drug Substances for Use in Compounding May Present Significant Safety Risks
- FDA: Bulk Drug Substances Nominated for Use in Compounding Under Section 503A
- USADA: 2018 Prohibited List Summary of Major Changes
- WADA: 2025 Prohibited List
- WADA: Prohibited List
- PubMed: Thymosin Beta-4 Accelerates Wound Healing
- PubMed: Thymosin Beta-4 Promotes Angiogenesis, Wound Healing, and Hair Growth
- PubMed: Thymosin Beta-4 and Angiogenesis
- PubMed: Thymosin Beta-4, a Multi-Functional Regenerative Peptide
- PubMed: The Regenerative Peptide Thymosin Beta-4 Accelerates Dermal Healing
- PMC: Thymosin Beta-4, Corneal Wound Healing, and Anti-Inflammatory Mechanisms
- ClinicalTrials.gov: Thymosin Beta-4 in Venous Stasis Ulcers
Frequently asked questions
What is TB-500?
TB-500 is commonly described as a synthetic peptide fragment related to thymosin beta-4, a naturally occurring peptide involved in actin regulation, cell migration, angiogenesis, and tissue-repair biology.
Is TB-500 FDA-approved?
No. TB-500 is not FDA-approved. FDA has identified safety concerns around thymosin beta-4 fragment products in the compounding context.
Is TB-500 the same as thymosin beta-4?
Not necessarily. TB-500 is commonly described as a fragment related to thymosin beta-4. Research on full thymosin beta-4 does not automatically prove that TB-500 products sold online are safe or effective.
Does TB-500 heal tendons?
Tendon-healing claims are not established by strong human clinical evidence. They are mostly extrapolated from thymosin beta-4 tissue-repair biology and preclinical studies.
Is TB-500 safe?
TB-500 does not have enough human safety data to call it safe. FDA says it has not identified human exposure data for drug products containing thymosin beta-4 fragment and warns about possible immunogenicity from aggregation and peptide-related impurities.
Is TB-500 banned in sports?
Yes. WADA prohibits thymosin beta-4 and its derivatives, including TB-500. Athletes subject to anti-doping rules should avoid it.
Sources
- [1]
- [2]
- [3]
- [4]WADA: 2025 Prohibited List
Anti Doping
- [5]WADA: Prohibited List
Anti Doping
- [6]
- [7]
- [8]
- [9]
- [10]
- [11]
- [12]ClinicalTrials.gov: Thymosin Beta-4 in Venous Stasis Ulcers
Clinical Trial Record
Last updated May 9, 2026